Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (341-350 of 425) with videos related to

Pageof 43
Sort By:
Reviews in Cardiovascular Medicine|July 30, 2024
Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care ModelsSamuel J Apple, Rachel Clark, Jonathan Daich, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2025
Plasma levels of small HDL particles are associated with coronary atherosclerosis progression in adults with diabetesBruna S B S Teles, Sergio H R Ramalho, Márcio S Bittencourt, et al.
American Journal of Preventive Cardiology|August 25, 2020
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive CardiologyAmit Khera, Seth J Baum, Ty J Gluckman, et al.
Diabetologia|November 7, 2020
Increased particle size of triacylglycerol-enriched remnant lipoproteins, but not their plasma concentration or lipid content, augments risk prediction of incident type 2 diabetesLuiz Sérgio F Carvalho, Isabela M Benseñor, Ana C C Nogueira, et al.
Journal of the American Heart Association|August 26, 2017
Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Sina Kianoush, Marcio S Bittencourt, Paulo A Lotufo, et al.
Pharmacological Research|June 13, 2017
The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trialsSorin Ursoniu, Dimitri P Mikhailidis, Maria-Corina Serban, et al.
American Journal of Preventive Cardiology|August 30, 2022
Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver diseasePeter P Toth, Gregory G Schwartz, Stephen J Nicholls, et al.
Clinical Cardiology|October 14, 2015
Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH RegistrySeth S Martin, Kamil F Faridi, Parag H Joshi, et al.
Journal of the American Heart Association|May 1, 2016
Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort StudiesParag H Joshi, Arif A Khokhar, Joseph M Massaro, et al.
Metabolites|October 29, 2020
Pasta Supplemented with <i>Opuntia ficus-indica</i> Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention StudyRosaria Vincenza Giglio, Giuseppe Carruba, Arrigo F G Cicero, et al.
Pageof 43

Showing results (341-350 of 425) with videos related to

Sort By:
Pageof 43
Reviews in Cardiovascular Medicine|July 30, 2024
Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care ModelsSamuel J Apple, Rachel Clark, Jonathan Daich, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2025
Plasma levels of small HDL particles are associated with coronary atherosclerosis progression in adults with diabetesBruna S B S Teles, Sergio H R Ramalho, Márcio S Bittencourt, et al.
American Journal of Preventive Cardiology|August 25, 2020
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive CardiologyAmit Khera, Seth J Baum, Ty J Gluckman, et al.
Diabetologia|November 7, 2020
Increased particle size of triacylglycerol-enriched remnant lipoproteins, but not their plasma concentration or lipid content, augments risk prediction of incident type 2 diabetesLuiz Sérgio F Carvalho, Isabela M Benseñor, Ana C C Nogueira, et al.
Journal of the American Heart Association|August 26, 2017
Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Sina Kianoush, Marcio S Bittencourt, Paulo A Lotufo, et al.
Pharmacological Research|June 13, 2017
The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trialsSorin Ursoniu, Dimitri P Mikhailidis, Maria-Corina Serban, et al.
American Journal of Preventive Cardiology|August 30, 2022
Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver diseasePeter P Toth, Gregory G Schwartz, Stephen J Nicholls, et al.
Clinical Cardiology|October 14, 2015
Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH RegistrySeth S Martin, Kamil F Faridi, Parag H Joshi, et al.
Journal of the American Heart Association|May 1, 2016
Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort StudiesParag H Joshi, Arif A Khokhar, Joseph M Massaro, et al.
Metabolites|October 29, 2020
Pasta Supplemented with <i>Opuntia ficus-indica</i> Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention StudyRosaria Vincenza Giglio, Giuseppe Carruba, Arrigo F G Cicero, et al.
Pageof 43